tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

NRIX Stock Latest News

Promising Data from Nurix Therapeutics’ Bexobrutideg Supports Buy Rating
RatingsPromising Data from Nurix Therapeutics’ Bexobrutideg Supports Buy Rating
6h ago
NRIX
Nurix Therapeutics’ Bexodeg: Promising Efficacy and Safety Profile Drive Buy Rating
PremiumRatings
Nurix Therapeutics’ Bexodeg: Promising Efficacy and Safety Profile Drive Buy Rating
7h ago
NRIX
Nurix Therapeutics price target lowered to $28 from $33 at H.C. Wainwright
PremiumThe Fly
Nurix Therapeutics price target lowered to $28 from $33 at H.C. Wainwright
7d ago
NRIX
Nurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Nurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment
8d ago
NRIX
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies
PremiumCompany Announcements
Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies
8d ago
NRIX
Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment
PremiumCompany AnnouncementsNurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment
8d ago
NRIX
Nurix Therapeutics’ NX-5948 Study: A Potential Game-Changer in Drug Delivery
Premium
Company Announcements
Nurix Therapeutics’ NX-5948 Study: A Potential Game-Changer in Drug Delivery
8d ago
NRIX
3 Best Stocks to Buy Now, 10/24/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 10/24/2025, According to Top Analysts
11d ago
EXOD
NRIX
Nurix Therapeutics price target lowered to $27 from $35 at BTIG
PremiumThe Fly
Nurix Therapeutics price target lowered to $27 from $35 at BTIG
12d ago
NRIX
Nurix Therapeutics price target lowered to $21 from $22 at Wells Fargo
PremiumThe Fly
Nurix Therapeutics price target lowered to $21 from $22 at Wells Fargo
12d ago
KYMR
NRIX
Nurix Therapeutics Announces $250M Stock Offering
PremiumCompany Announcements
Nurix Therapeutics Announces $250M Stock Offering
13d ago
8K
NRIX
Nurix Therapeutics price target raised to $29 from $28 at RBC Capital
PremiumThe Fly
Nurix Therapeutics price target raised to $29 from $28 at RBC Capital
13d ago
NRIX
Nurix Therapeutics Initiates DAYBreak Phase 2 Trial
PremiumCompany AnnouncementsNurix Therapeutics Initiates DAYBreak Phase 2 Trial
13d ago
8K
NRIX
Nurix prices 24.5M shares at $10.21 in underwritten registered offering
Premium
The Fly
Nurix prices 24.5M shares at $10.21 in underwritten registered offering
13d ago
NRIX
Nurix Therapeutics initiates DAYBreak clinical trial
Premium
The Fly
Nurix Therapeutics initiates DAYBreak clinical trial
13d ago
NRIX
Nurix Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Nurix Therapeutics initiated with an Outperform at Mizuho
15d ago
NRIX
Promising Potential and Strategic Pipeline: A Buy Recommendation for Nurix Therapeutics
PremiumRatings
Promising Potential and Strategic Pipeline: A Buy Recommendation for Nurix Therapeutics
15d ago
NRIX
Promising Clinical Results of NX-1607 Support Buy Rating for Nurix Therapeutics
PremiumRatings
Promising Clinical Results of NX-1607 Support Buy Rating for Nurix Therapeutics
15d ago
NRIX
Nurix Therapeutics announces new clinical data from Phase 1a study NX-1607
PremiumThe Fly
Nurix Therapeutics announces new clinical data from Phase 1a study NX-1607
16d ago
NRIX
Nurix Therapeutics: Strong Cash Position and Upcoming Clinical Milestones Justify Buy Rating Despite Larger Net Loss
PremiumRatingsNurix Therapeutics: Strong Cash Position and Upcoming Clinical Milestones Justify Buy Rating Despite Larger Net Loss
21d ago
NRIX
Nurix Therapeutics price target lowered to $33 from $34 at H.C. Wainwright
Premium
The Fly
Nurix Therapeutics price target lowered to $33 from $34 at H.C. Wainwright
21d ago
NRIX
Nurix Therapeutics Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Nurix Therapeutics Reports Increased Losses Amid R&D Expansion
22d ago
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >